Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MHTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2024 -2.342M
March 31, 2024 -2.184M
December 31, 2023 -1.802M
September 30, 2023 -1.548M
June 30, 2023 -1.286M
March 31, 2023 -1.057M
December 31, 2022 -0.637M
September 30, 2022 -0.241M
June 30, 2022 -0.17M
March 31, 2022 1.446M
December 31, 2021 2.093M
September 30, 2021 2.127M
June 30, 2021 3.283M
March 31, 2021 5.866M
December 31, 2020 5.732M
September 30, 2020 1.634M
June 30, 2020 -0.151M
March 31, 2020 -0.679M
December 31, 2019 0.053M
September 30, 2019 1.16M
June 30, 2019 -0.069M
March 31, 2019 0.472M
December 31, 2018 0.908M
September 30, 2018 4.502M
June 30, 2018 4.178M
Date Value
March 31, 2018 6.391M
December 31, 2017 9.219M
September 30, 2017 13.28M
June 30, 2017 13.89M
March 31, 2017 9.737M
December 31, 2016 3.781M
September 30, 2016 4.551M
June 30, 2016 5.902M
March 31, 2016 7.813M
December 31, 2015 9.652M
September 30, 2015 10.20M
June 30, 2015 12.40M
March 31, 2015 13.07M
December 31, 2014 0.226M
September 30, 2014 -1.056M
June 30, 2014 -0.704M
March 31, 2014 -0.429M
December 31, 2013 -1.18M
September 30, 2013 -1.832M
June 30, 2013 -1.194M
March 31, 2013 -0.735M
December 31, 2012 -0.797M
September 30, 2012 -0.654M
June 30, 2012 -0.62M
March 31, 2012 -0.208M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 113.59M
Exicure, Inc. 0.977M
Century Therapeutics, Inc. 232.34M
Absci Corp. 246.13M
Celularity, Inc. -38.06M